Orthofix Medical (OFIX)

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
ESG term mentions
In last year of SEC filings
CarbonCarbon FootprintCircularCircular EconomyClimateClimate ChangeConflict MineralsEcosystemEnvironmentEnvironmentalLandfillLife CycleMaterialsNatureOffsetPackagePackagingPandemicPlasticRaw MaterialsRecycleRecyclingRegenerationRegenerativeWasteAccessAfrican AmericanAsianAttritionBenefitsBlackCharitableCollective BargainingCommunityCommunity EngagementCultureCustomerCustomer SatisfactionCyberCybersecurityData PrivacyDeathDemographicDisabilityDiversityDiversity and InclusionEmployeeEngagementEthnicityGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHireHiringHispanicHuman CapitalHuman ResourcesHuman RightsIncidentInjuriesInjuryLatinxLGBTQOpioidOSHAOvertimeParental LeavePay for PerformancePerquisitesPrivacyProduct QualityProduct SafetyRecallRecruitRecruitmentReimbursementRetentionRetirementSafetySatisfactionSkillSkilledSkillsSocialSocietalStakeholderSupplierSupply ChainSupply Chain ManagementTalentTrainingUnionViolenceVolunteerWomenWorkersWorkforceAnti-corruptionAssessmentAssuranceAuditBoard RefreshmentBonusBribeBriberyClassifiedClawbackCommitmentConflict of InterestCorporate GovernanceCorporate PurposeDepartment ofEnterprise Risk ManagementESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIndependenceIndependentIndependent ChairInnovateInnovationInnovativeInvestigationLawsuitLead Independent DirectorLeadershipLitigationLong-termMajorityMissionOverseeOversightPerquisitePledgingPoison PillProcurementPurposeQuality StandardR&DRecoupReputationReputationalResearch and DevelopmentResponsibilityResponsibleShareholder ProposalsSpecial MeetingStewardshipStrategySupermajoritySustainabilitySustainableTargetsTaxTenureTransparencyVoting Rights
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On June 21, 2021, the Company held the Annual Meeting. The total number of common shares eligible to vote as of the record date, April 22, 2021, was 19,558,752 and, pursuant to the Company’s Bylaws, 9,779,377 shares were required to be present or represented at the Annual Meeting to constitute a quorum. The total number of common shares present or represented at the Annual Meeting was 18,300,784, and a quorum therefore existed. Of the shares present and represented, 903,637 constituted broker non-votes for purposes of items 1, 2, 3 and 4 below.

At the Annual Meeting:
1.Election of Board of Directors. The following persons were elected by a plurality of the votes cast at the Annual Meeting as directors of the Company for a one year term expiring at the 2022 Annual Meeting of Shareholders:

NameVotes ForVotes AgainstAbstentions
Catherine M. Burzik17,197,010 (98.85%)199,738 (1.15%)399 (0.0%)
Jason M. Hannon16,423,361 (94.40%)973,347 (5.59%)439 (0.0%)
James F. Hinrichs15,870,804 (91.23%)1,524,496 (8.76%)1,847 (0.01%)
Alex V. Lukianov17,172,051 (98.71%)223,172 (1.28%)1,924 (0.01%)
Lilly Marks16,867,520 (96.96%)527,695 (3.03%)1,932 (0.01%)
Michael E. Paolucci16,867,216 (96.95%)528,084 (3.04%)1,847 (0.01%)
Jon Serbousek17,268,812 (99.26%)124,039 (0.71%)4,296 (0.02%)
John Sicard17,219,962 (98.98%)175,401 (1.01%)1,784 (0.01%)

2.Advisory and Non-Binding Resolution to Approve Executive Compensation. The advisory and non-binding resolution to approve executive compensation was approved by a vote of (i) 16,849,118 (96.85%) in favor, (ii) 545,768 (3.14%) against, and (iii) 2,261 (0.01%) abstaining.

3.Approval of Amendment No. 2 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan. Amendment No. 2 to the Company’s Amended and Restated 2012 Long-Term Incentive Plan was approved by a vote of (i) 14,692,839 (84.46%) in favor, (ii) 2,701,414 (15.53%) against, and (iii) 2,894 (0.02%) abstaining
4.Approval of Amendment No. 2 to the Company’s Second Amended and Restated Stock Purchase Plan. Amendment No. 2 to the Company’s Second Amended and Restated Stock Purchase Plan was approved by a vote of (i) 17,341,445 (99.68%) in favor, (ii) 54,417 (0.31%) against, and (iii) 1,285 (0.01%) abstaining.
5.Ratification of the Selection of Ernst & Young LLP. The selection of Ernst & Young LLP to act as the independent registered public accounting firm for the Company and its subsidiaries for the fiscal year ending December 31, 2021 was ratified by a vote of (i) 18,069,898 (98.74%) in favor, (ii) 230,647 (1.26%) against, and (iii) 239 (0.0%) abstaining.